Table 3.
Accelerometry determined physical activity for bouts ≥6 METs per minute for ≥10 minutes in duration by categories of BMI, sex, race/ethnicity, age, fitness, diabetes treatment, and cardiovascular disease history (mean ± standard deviation).
| Variable | Categories | Bouts per Day | Minutes per Bout* | METs per Minute* | MET-minutes* |
|---|---|---|---|---|---|
| BMI | 25.0 to <27.0 kg/m2 | 0.13 ± 0.34 (N=46) | 18.77 ± 7.83 (N=12) | 8.34 ± 1.61 (N=12) | 158.3 ± 82.38 (N=12) |
| 27.0 to <30.0 kg/m2 | 0.18 ± 0.35 (N=235) | 20.09 ± 9.88 (N=73) | 8.06 ± 1.24 (N=73) | 165.3 ± 94.85 (N=73) | |
| 30.0 to <35.0 kg/m2 | 0.15 ± 0.39 (N=719) | 19.49 ± 9.85 (N=217) | 8.03 ± 1.20 (N=217) | 159.7 ± 93.99 (N=217) | |
| 35.0 to <40.0 kg/m2 | 0.11 ± 0.28 (N=619) | 18.01 ± 7.97 (N=158) | 7.72 ± 0.99 (N=158) | 140.8 ± 74.29 (N=158) | |
| ≥40 kg/m2 | 0.06 ± 0.17 (N=525) | 17.08 ± 6.98 (N=97) | 7.36 ± 0.92 (N=97) | 127.7 ± 64.50 (N=97) | |
| p-value | <.0001 | 0.1051 | <.0001 | 0.0075 | |
| Sex | Men | 0.16 ± 0.35 (N=917) | 18.61 ± 8.71 (N=301) | 8.05 ± 1.18 (N=301) | 152.6 ± 84.02 (N=301) |
| Women | 0.09 ± 0.28 (N=1228) | 18.83 ± 9.11 (N=256) | 7.58 ± 1.04 (N=256) | 145.8 ± 85.68 (N=256) | |
| p-value | <.0001 | 0.7652 | <.0001 | 0.3443 | |
| Race/Ethnicity | African American/Black | 0.07 ± 0.17 (N=401) | 20.66 ± 10.03 (N=74) | 7.65 ± 1.01 (N=74) | 160.3 ± 89.73 (N=74) |
| White | 0.13 ± 0.31 (N=1563) | 18.29 ± 8.45 (N=433) | 7.85 ± 1.16 (N=433) | 146.5 ± 81.35 (N=433) | |
| Hispanic | 0.19 ± 0.63 (N=107) | 20.19 ± 11.48 (N=34) | 7.88 ± 1.09 (N=34) | 164.9 ± 117.7 (N=34) | |
| Other/Mixed/Missing | 0.12 ± 0.25 (N=74) | 18.07 ± 7.97 (N=16) | 8.13 ± 1.22 (N=16) | 146.9 ± 69.13 (N=16) | |
| p-value | 0.0005 | 0.1334 | 0.3776 | 0.4133 | |
| Age | <50 years | 0.10 ± 0.20 (N=208) | 20.52 ± 11.21 (N=62) | 8.00 ± 1.34 (N=62) | 168.1 ± 111.5 (N=62) |
| 50 to <60 years | 0.12 ± 0.32 (N=964) | 19.42 ± 8.60 (N=253) | 7.89 ± 1.18 (N=253) | 156.0 ± 82.88 (N=253) | |
| 60 to <70 years | 0.13 ± 0.34 (N=811) | 17.41 ± 8.35 (N=212) | 7.75 ± 1.03 (N=212) | 137.3 ± 77.29 (N=212) | |
| ≥70 years | 0.08 ± 0.23 (N=162) | 18.20 ± 8.75 (N=30) | 7.60 ± 1.11 (N=30) | 141.3 ± 78.77 (N=30) | |
| p-value | 0.2060 | 0.0320 | 0.2190 | 0.0267 | |
| Fitness | <6 METs | 0.03 ± 0.13 (N=645) | 15.69 ± 5.92 (N=64) | 6.58 ± 0.32 (N=64) | 103.4 ± 40.02 (N=64) |
| 6 to <8 METs | 0.11 ± 0.25 (N=881) | 17.18 ± 6.79 (N=232) | 7.61 ± 0.66 (N=232) | 131.9 ± 57.38 (N=232) | |
| 8 to <10 METs | 0.20 ± 0.46 (N=435) | 19.09 ± 9.46 (N=165) | 8.18 ± 1.20 (N=165) | 158.8 ± 92.70 (N=165) | |
| ≥10 METs | 0.30 ± 0.47 (N=181) | 23.78 ± 11.59 (N=96) | 8.61 ± 1.43 (N=96) | 206.5 ± 111.9 (N=96) | |
| p-value | <.0001 | <.0001 | <.0001 | <.0001 | |
| Diabetes Medication | No Glucose Lowering Medication | 0.15 ± 0.32 (N=267) | 17.79 ± 6.44 (N=78) | 7.75 ± 1.07 (N=78) | 139.1 ± 56.10 (N=78) |
| Glucose Lowering Medication (Not including insulin or thiazolidinedione) | 0.13 ± 0.36 (N=967) | 18.99 ± 8.76 (N=256) | 7.89 ± 1.19 (N=256) | 152.9 ± 84.81 (N=256) | |
| Thiazolidinedione | 0.10 ± 0.26 (N=482) | 18.85 ± 10.54 (N=126) | 7.82 ± 1.10 (N=126) | 151.4 ± 99.30 (N=126) | |
| Insulin Alone | 0.13 ± 0.29 (N=86) | 18.48 ± 8.84 (N=21) | 7.71 ± 1.24 (N=21) | 145.1 ± 83.28 (N=21) | |
| Insulin plus glucose lowering medication (Not including thiazolidinedione) | 0.09 ± 0.22 (N=153) | 18.64 ± 8.36 (N=31) | 7.76 ± 0.97 (N=31) | 145.2 ± 72.21 (N=31) | |
| Insulin plus thiazolidinedione | 0.09 ± 0.22 (N=157) | 17.91 ± 8.70 (N=40) | 7.75 ± 1.21 (N=40) | 142.3 ± 93.78 (N=40) | |
| p-value | 0.1566 | 0.9196 | 0.9027 | 0.8412 | |
| Cardiovascular Disease History | No | 0.11 ± 0.30 (N=329) | 17.51 ± 8.08 (N=75) | 7.70 ± 1.02 (N=75) | 138.3 ± 82.72 (N=75) |
| Yes | 0.12 ± 0.31 (N=1816) | 18.90 ± 9.00 (N=482) | 7.86 ± 1.16 (N=482) | 151.2 ± 85.04 (N=482) | |
| p-value | 0.4194 | 0.2087 | 0.2734 | 0.2189 |
*
Indicates that data represent participants who reported ≥1 bout during the observation period that met the criteria of ≥6 METs per minute and ≥10 minutes for that bout.